Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in KALA — KALA BIO, Inc.

CIK 886982 NEW YORK, NY
Back to KALA Full portfolio

Position in KALA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,893
+$16,463 QoQ
Shares Held
10,921
+3786.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 15 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KALA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,246,746 across 360 Biotechnology names. KALA ranks #344 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in KALA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,893 10,921
2026-03-31 $2,430 14,048
2022-09-30 $2 10,741
2022-06-30 $73,175 243,918
2022-03-31 $123,042 89,162
2021-12-31 $246,250 203,514
2021-09-30 $405,986 154,957
2021-06-30 $852,022 160,759
2021-03-31 $595,391 88,337
2020-12-31 $318,530 46,981
2020-09-30 $1,412,234 188,298
2020-06-30 $3,337,596 317,564
2020-03-31 $3,816,696 434,209